Literature DB >> 25029456

Heart rate variability analysis and weaning from mechanical ventilation: lessons from exercise physiology.

Andry Van de Louw.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25029456      PMCID: PMC4057380          DOI: 10.1186/cc13848

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

In the previous issue of Critical Care, I read with interest the article by Huang and colleagues, who suggested that heart rate variability (HRV) changes might predict the success of ventilator weaning [1]. Although this perspective is attractive, a methodological issue must be highlighted. The fast Fourier transform, as used by the authors to assess HRV, produces a spectrogram of power spectral density characterized by two peaks of variability - low frequency and high frequency (HF) - the latter of which is centered at the respiratory rate [2,3]. The recommendation of the Task Force [4] to use the range of 0.15 to 0.4 Hz (9 to 24 respirations per minute) to compute HRV in the HF band assumes that this range will include the respiratory rate, which is true in most clinical situations. However, in more extreme conditions, like heavy exercise, the actual respiratory rate may be out of this range, and therefore most studies on HRV during exercise used a range from 0.1 to 0.8 (or even 1) Hz to compute HRV in HF [5,6]. Likewise, patients undergoing weaning from mechanical ventilation can be tachypneic; the authors used a respiratory rate as high as 35 respirations per minute as a criterion for a failed spontaneous breathing trial (SBT), and such respiratory rates are obviously outside the range (0.15 to 0.4 Hz) chosen to compute HF HRV. We suggest that, in patients failing an SBT or extubation, respiratory rate may increase and shift the HF peak of HRV toward the right of the spectrogram, above 0.4 Hz, mistakenly decreasing the HF HRV if computed in the range of 0.15 to 0.4 Hz. This might account for the lack of difference in HF HRV between successful/failed weaning, while a difference in total power was observed. I believe that future studies should take this methodological issue into consideration.

Abbreviations

HF: High frequency; HRV: Heart rate variability; SBT: Spontaneous breathing trial.

Competing interests

The author declares that he has no competing interests.
  6 in total

1.  Spectral analysis of heart rate variability during exercise in trained subjects.

Authors:  Aurélien P Pichon; Claire de Bisschop; Manuel Roulaud; André Denjean; Yves Papelier
Journal:  Med Sci Sports Exerc       Date:  2004-10       Impact factor: 5.411

2.  Effect of heavy exercise on spectral baroreflex sensitivity, heart rate, and blood pressure variability in well-trained humans.

Authors:  François Cottin; Claire Médigue; Yves Papelier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-11       Impact factor: 4.733

3.  Breathing cardiovascular variability and baroreflex in mechanically ventilated patients.

Authors:  Andry Van de Louw; Claire Médigue; Yves Papelier; François Cottin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-15       Impact factor: 3.619

4.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog.

Authors:  M Pagani; F Lombardi; S Guzzetti; O Rimoldi; R Furlan; P Pizzinelli; G Sandrone; G Malfatto; S Dell'Orto; E Piccaluga
Journal:  Circ Res       Date:  1986-08       Impact factor: 17.367

6.  Application of heart-rate variability in patients undergoing weaning from mechanical ventilation.

Authors:  Chun-Ta Huang; Yi-Ju Tsai; Jou-Wei Lin; Sheng-Yuan Ruan; Huey-Dong Wu; Chong-Jen Yu
Journal:  Crit Care       Date:  2014-01-23       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.